chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: Nausea; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Sore arm; Itcing at injection site; Redness at the injection site; Swelling at the injection site; Tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (Itcing at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (Itcing at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site). At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (Itcing at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine administered from a vial punctured more than 18 hours ago; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered from a vial punctured more than 18 hours ago) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medically reported history).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered from a vial punctured more than 18 hours ago). On 11-Mar-2021, EXPIRED PRODUCT ADMINISTERED (vaccine administered from a vial punctured more than 18 hours ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Company comment:This report refers to a case of expired vaccine used for mRNA-1273, lot # 027A21A  with no associated AEs; Sender's Comments: This report refers to a case of expired vaccine used for mRNA-1273, lot # 027A21A  with no associated AEs
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Extended dosing interval (>42 days); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Extended dosing interval (>42 days)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Extended dosing interval (>42 days)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Extended dosing interval (>42 days)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided. No Treatment information was  provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was sore/there was pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore/there was pain in her arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was sore/there was pain in her arm). At the time of the report, PAIN IN EXTREMITY (arm was sore/there was pain in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Rash
Clinical narrative: Shooting pains in left side neck; Rash on left Shoulder; Pain in shoulder felt like bees stinging; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Shooting pains in left side neck), RASH (Rash on left Shoulder) and ARTHRALGIA (Pain in shoulder felt like bees stinging) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy (Gastro Sensitivity.). Concomitant products included LISINOPRIL for Blood pressure, SIMVASTATIN for Cholesterol, FAMOTIDINE for Reflux oesophagitis, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and FISH OIL for an unknown indication.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced PAIN (Shooting pains in left side neck), RASH (Rash on left Shoulder) and ARTHRALGIA (Pain in shoulder felt like bees stinging). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) on 31-Dec-2020 for Adverse reaction, at a dose of 50 milligram. At the time of the report, PAIN (Shooting pains in left side neck), RASH (Rash on left Shoulder) and ARTHRALGIA (Pain in shoulder felt like bees stinging) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was taken to urgent care and watched for couple of hours.   This case was linked to MOD-2021-037399 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Added demographics, concomitant drugs and event outcome updated.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia, Peripheral swelling, Pruritus, Rash
Clinical narrative: itching with first dose; swelling of arm; rash; achy body; pain of arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching with first dose), PERIPHERAL SWELLING (swelling of arm), RASH (rash), MYALGIA (achy body) and INJECTION SITE PAIN (pain of arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 027A21A) for COVID-19 vaccination.     Concomitant products included METFORMIN, ATORVASTATIN, LEVOTHYROXINE and VITAMIN D NOS for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PRURITUS (itching with first dose), PERIPHERAL SWELLING (swelling of arm), RASH (rash), MYALGIA (achy body) and INJECTION SITE PAIN (pain of arm). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Rash, at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) for Headache, at an unspecified dose and frequency. At the time of the report, PRURITUS (itching with first dose), RASH (rash) and MYALGIA (achy body) had resolved and PERIPHERAL SWELLING (swelling of arm) and INJECTION SITE PAIN (pain of arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-043665 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Suspect batch number updated, concomitant medication information updated, outcome and reporter causality of rash, myalgia and pruritus updated.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Chills, Headache, Tachycardia
Clinical narrative: i've had tachycardia before but this was extreme; shaking; headache; chills; joints hurt; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (i've had tachycardia before but this was extreme), TREMOR (shaking), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joints hurt) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Tachycardia. Concomitant products included CARVEDILOL and HYDROCHLOROTHIAZIDE for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced TACHYCARDIA (i've had tachycardia before but this was extreme), TREMOR (shaking), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joints hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (i've had tachycardia before but this was extreme), TREMOR (shaking), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joints hurt) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, COVID-19: positive positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: i've had tachycardia before but this was extreme; shaking; headache; chills; joints hurt; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (i've had tachycardia before but this was extreme), TREMOR (shaking), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joints hurt) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Tachycardia. Concomitant products included CARVEDILOL and HYDROCHLOROTHIAZIDE for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced TACHYCARDIA (i've had tachycardia before but this was extreme), TREMOR (shaking), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joints hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (i've had tachycardia before but this was extreme), TREMOR (shaking), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joints hurt) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, COVID-19: positive positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Fatigue, Feeling cold, Gait inability
Clinical narrative: Cold feeling comes and goes; Can't get up and go; Felt "punky"; Felt like she had no strength" in her legs and felt "punky/ felt weak in her legs; Balance was off; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt like she had no strength" in her legs and felt "punky/ felt weak in her legs), BALANCE DISORDER (Balance was off), FEELING COLD (Cold feeling comes and goes), GAIT INABILITY (Can't get up and go) and FATIGUE (Felt "punky") in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation, Reflux esophagitis, High cholesterol and Allergy to antibiotic (Allergic to antibiotic (name unspecified)). Concomitant products included PRAVASTATIN, FAMOTIDINE and DILTIAZEM for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ASTHENIA (Felt like she had no strength" in her legs and felt "punky/ felt weak in her legs), BALANCE DISORDER (Balance was off), GAIT INABILITY (Can't get up and go) and FATIGUE (Felt "punky"). On 11-Mar-2021, the patient experienced FEELING COLD (Cold feeling comes and goes). At the time of the report, ASTHENIA (Felt like she had no strength" in her legs and felt "punky/ felt weak in her legs), BALANCE DISORDER (Balance was off), FEELING COLD (Cold feeling comes and goes), GAIT INABILITY (Can't get up and go) and FATIGUE (Felt "punky") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: Arm of injection is swollen; Arm of injection itchy; Arm of injection is red; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021 and was forwarded to Moderna on 11-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm of injection is swollen), PRURITUS (Arm of injection itchy) and ERYTHEMA (Arm of injection is red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE, LOVASTATIN, LOSARTAN, ESCITALOPRAM and VITAMINS NOS for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm of injection is swollen), PRURITUS (Arm of injection itchy) and ERYTHEMA (Arm of injection is red). At the time of the report, PERIPHERAL SWELLING (Arm of injection is swollen), PRURITUS (Arm of injection itchy) and ERYTHEMA (Arm of injection is red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not take any corrective medication.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative, SARS-CoV-2 antibody test
Clinical narrative: Took an antibody test twice and it came back as negative; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (Took an antibody test twice and it came back as negative) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced ANTIBODY TEST NEGATIVE (Took an antibody test twice and it came back as negative). At the time of the report, ANTIBODY TEST NEGATIVE (Took an antibody test twice and it came back as negative) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 antibody test: negative (Negative) Took an antibody test twice and it came back as negative..         Concomitant medications included medications for chemotherapy (three different medications) and immunosuppressants.  No treatment information was provided.  Very limited information has been provided for the event at this time. Further information has been requested. However, date of testing the antibodies and the chemo therapy drug details are required for further evaluation.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant followup appended. Patient demographics added.; Sender's Comments: Very limited information has been provided for the event at this time. Further information has been requested. However, date of testing the antibodies and the chemo therapy drug details are required for further evaluation.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Limb discomfort
Clinical narrative: Fatigue; checked the temperature again and this time it was 100.7; checked temperature again which was around 104.4; muscle soreness in the thigh; bad headache; chills; 1 hour afterward had a low grade fever with 99.6; Around 8 or 9 pm, fever rose up to 102; soreness in the arm; shaking; This spontaneous case was reported by a physician and describes the occurrence of LIMB DISCOMFORT (soreness in the arm), TREMOR (shaking), FATIGUE (Fatigue), PYREXIA (Around 8 or 9 pm, fever rose up to 102) and PYREXIA (checked the temperature again and this time it was 100.7) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lupus nephritis (.). Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN D3 and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced LIMB DISCOMFORT (soreness in the arm), TREMOR (shaking), PYREXIA (Around 8 or 9 pm, fever rose up to 102), CHILLS (chills) and PYREXIA (1 hour afterward had a low grade fever with 99.6). On 20-Feb-2021, the patient experienced FATIGUE (Fatigue), PYREXIA (checked the temperature again and this time it was 100.7), PYREXIA (checked temperature again which was around 104.4), ARTHRALGIA (muscle soreness in the thigh) and HEADACHE (bad headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 20-Feb-2021, ARTHRALGIA (muscle soreness in the thigh) had resolved. On 21-Feb-2021, LIMB DISCOMFORT (soreness in the arm), TREMOR (shaking), FATIGUE (Fatigue), PYREXIA (Around 8 or 9 pm, fever rose up to 102), PYREXIA (checked the temperature again and this time it was 100.7), PYREXIA (checked temperature again which was around 104.4), CHILLS (chills), PYREXIA (1 hour afterward had a low grade fever with 99.6) and HEADACHE (bad headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-020621 (Patient Link).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: Fatigue; checked the temperature again and this time it was 100.7; checked temperature again which was around 104.4; muscle soreness in the thigh; bad headache; chills; 1 hour afterward had a low grade fever with 99.6; Around 8 or 9 pm, fever rose up to 102; soreness in the arm; shaking; This spontaneous case was reported by a physician and describes the occurrence of LIMB DISCOMFORT (soreness in the arm), TREMOR (shaking), FATIGUE (Fatigue), PYREXIA (Around 8 or 9 pm, fever rose up to 102) and PYREXIA (checked the temperature again and this time it was 100.7) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lupus nephritis (.). Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN D3 and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced LIMB DISCOMFORT (soreness in the arm), TREMOR (shaking), PYREXIA (Around 8 or 9 pm, fever rose up to 102), CHILLS (chills) and PYREXIA (1 hour afterward had a low grade fever with 99.6). On 20-Feb-2021, the patient experienced FATIGUE (Fatigue), PYREXIA (checked the temperature again and this time it was 100.7), PYREXIA (checked temperature again which was around 104.4), ARTHRALGIA (muscle soreness in the thigh) and HEADACHE (bad headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 20-Feb-2021, ARTHRALGIA (muscle soreness in the thigh) had resolved. On 21-Feb-2021, LIMB DISCOMFORT (soreness in the arm), TREMOR (shaking), FATIGUE (Fatigue), PYREXIA (Around 8 or 9 pm, fever rose up to 102), PYREXIA (checked the temperature again and this time it was 100.7), PYREXIA (checked temperature again which was around 104.4), CHILLS (chills), PYREXIA (1 hour afterward had a low grade fever with 99.6) and HEADACHE (bad headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-020621 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: when she received her second dose it also hurt a lot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (when she received her second dose it also hurt a lot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (when she received her second dose it also hurt a lot). At the time of the report, VACCINATION SITE PAIN (when she received her second dose it also hurt a lot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered VACCINATION SITE PAIN (when she received her second dose it also hurt a lot) to be not applicable.    Treatment information were not provided.   Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: sore arm; extreme weakness; fever; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ASTHENIA (extreme weakness), PYREXIA (fever) and NAUSEA (extreme nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis. Concomitant products included SARILUMAB for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), ASTHENIA (extreme weakness), PYREXIA (fever) and NAUSEA (extreme nausea). At the time of the report, PAIN IN EXTREMITY (sore arm), ASTHENIA (extreme weakness), PYREXIA (fever) and NAUSEA (extreme nausea) outcome was unknown.            No treatment information was provided.    This case was linked to MOD-2021-015011 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose was not administered till now; A spontaneous report was received from a other healthcare professional concerning a patient of unknown age and gender, who received Moderna's COVID-19 vaccine (mRNA -1273) and due to the relocation issues second dose was not administered till now marking 60 days/product dose omission issue.  The patient's medical history was not provided. Concomitant medications were not reported.  On 11 JAN 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection.   The patient got vaccinated and due to the relocation issues second dose was not administered till now marking 60 days.   Treatment details were not mentioned.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event due to the relocation issues second dose was not administered till now marking 60 days was resolved.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated AEs reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Nausea
Clinical narrative: Nausea; Knee giving problem, hurt a lot; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and ARTHRALGIA (Knee giving problem, hurt a lot) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea) and ARTHRALGIA (Knee giving problem, hurt a lot). At the time of the report, NAUSEA (Nausea) and ARTHRALGIA (Knee giving problem, hurt a lot) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site reaction
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm) and RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm) and RASH (Rash). At the time of the report, VACCINATION SITE REACTION (covid arm) and RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site pain
Clinical narrative: I couldn't lift up my arm; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (I couldn't lift up my arm) and VACCINATION SITE PAIN (Vaccination site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Ambidexterity. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced LIMB DISCOMFORT (I couldn't lift up my arm) and VACCINATION SITE PAIN (Vaccination site pain). The patient was treated with IBUPROFEN for Injection site pain, at a dose of 300 mg. At the time of the report, LIMB DISCOMFORT (I couldn't lift up my arm) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles affected his right side around his waist) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HERPES ZOSTER (Shingles affected his right side around his waist). At the time of the report, HERPES ZOSTER (Shingles affected his right side around his waist) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided by the reporter.  Patient started getting symptoms 5 days after the first dose and was later diagnosed with shingles. No treatment information was provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; A spontaneous report was received from a consumer, concerning  a 78 years adult male patient, who received Moderna COVID-19 Vaccine and experienced 1 dose.  The patient's medical history was not provided.  The concomitant products was cholesterol and blood pressure.  On  22-Jan-2021,prior to the onset of events,the patient received the first dose of  mRNA-1273(lot number: 030L20A) and on 19-Feb-2021 the patient received the second dose  and route of administration is  intramuscular (lot number : 006M20A) route for COVID-19 infection prophylaxis.  Treatment history was she has been taking Tylenol,Nyquil and Dayquil.  Action taken with mRNA-1273 in response to the events were not reported.  The Outcome of the event(s)  chills was considered to be not resolved at the time of this report.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: numbness in left arm, through left breast and armpits; numbness and tingling lasted for four hours; more she used her arm,the more numbness she experienced; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in left arm, through left breast and armpits), PARAESTHESIA (numbness and tingling lasted for four hours) and HYPOAESTHESIA (more she used her arm,the more numbness she experienced) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L70A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced HYPOAESTHESIA (numbness in left arm, through left breast and armpits), PARAESTHESIA (numbness and tingling lasted for four hours) and HYPOAESTHESIA (more she used her arm,the more numbness she experienced). On 13-Feb-2021, HYPOAESTHESIA (numbness in left arm, through left breast and armpits), PARAESTHESIA (numbness and tingling lasted for four hours) and HYPOAESTHESIA (more she used her arm,the more numbness she experienced) had resolved.            No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-015162 (Patient Link).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after first dose) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (Sore arm after first dose) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported. No treatment information was provided. The reactions settled in a few days. No further issues were reported.   This case was linked to MOD-2021-024371 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: TCR Attached
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mild arm ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Mild arm ache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L208 and 031L20A) for COVID-19 vaccination.     No medical history was not reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE PAIN (Mild arm ache). On 07-Feb-2021, VACCINATION SITE PAIN (Mild arm ache) had resolved. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  Relevant concomitant medications included, multivitamin was reported.   Treatment information was not provided.    This case was linked.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash, Nausea, Oropharyngeal pain
Clinical narrative: Sore throat; Nauseous; Red arm; Red mark that is about two inches in all the way around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), NAUSEA (Nauseous), INJECTION SITE ERYTHEMA (Red arm) and INJECTION SITE RASH (Red mark that is about two inches in all the way around the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K208 and 043L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), NAUSEA (Nauseous), INJECTION SITE ERYTHEMA (Red arm) and INJECTION SITE RASH (Red mark that is about two inches in all the way around the injection site). On 07-Feb-2021, NAUSEA (Nauseous) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), INJECTION SITE ERYTHEMA (Red arm) and INJECTION SITE RASH (Red mark that is about two inches in all the way around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 01-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Myalgia
Clinical narrative: muscle pains; joint pain; threw up; worst chills; teeth chattering; temperature went up to 101F; fatigue; being tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (worst chills), CHILLS (teeth chattering), FEELING ABNORMAL (threw up), PYREXIA (temperature went up to 101F) and FATIGUE (fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M00A or 030N00A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced CHILLS (worst chills), CHILLS (teeth chattering), FEELING ABNORMAL (threw up), PYREXIA (temperature went up to 101F), FATIGUE (fatigue) and FATIGUE (being tired). On an unknown date, the patient experienced MYALGIA (muscle pains) and ARTHRALGIA (joint pain). At the time of the report, CHILLS (worst chills), CHILLS (teeth chattering), FEELING ABNORMAL (threw up), PYREXIA (temperature went up to 101F), FATIGUE (fatigue), FATIGUE (being tired), MYALGIA (muscle pains) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included Unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: muscle pains; joint pain; threw up; worst chills; teeth chattering; temperature went up to 101F; fatigue; being tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (worst chills), CHILLS (teeth chattering), FEELING ABNORMAL (threw up), PYREXIA (temperature went up to 101F) and FATIGUE (fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M00A or 030N00A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced CHILLS (worst chills), CHILLS (teeth chattering), FEELING ABNORMAL (threw up), PYREXIA (temperature went up to 101F), FATIGUE (fatigue) and FATIGUE (being tired). On an unknown date, the patient experienced MYALGIA (muscle pains) and ARTHRALGIA (joint pain). At the time of the report, CHILLS (worst chills), CHILLS (teeth chattering), FEELING ABNORMAL (threw up), PYREXIA (temperature went up to 101F), FATIGUE (fatigue), FATIGUE (being tired), MYALGIA (muscle pains) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included Unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itch on her back; Rash on her back; A spontaneous report was received from a consumer concerning a 78-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pruritus (itch on her back) and rash (rash on her back).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 025A21A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced Itch and Rash on her back.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity
Clinical narrative: Body ache; muscle PAIN; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle PAIN) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included Arthritis (she was diagnosed with arthritis and gout and at that time she did not know they were autoimmune disease.), Gout, COVID-19 in November 2020 and Pneumonia in November 2020.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 06-Mar-2021, the patient experienced PAIN (Body ache) and MYALGIA (muscle PAIN). On 07-Mar-2021, PAIN (Body ache), PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle PAIN) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication was not reported. No treatment medication was not reported
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypokinesia, Injection site warmth, Migraine, Vaccination site rash
Clinical narrative: hot or warm to touch injection site; migraine; slightly difficult to move injected arm, can only move it one foot; rash is around the injection site; Bad Headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (hot or warm to touch injection site), MIGRAINE (migraine), HYPOKINESIA (slightly difficult to move injected arm, can only move it one foot), VACCINATION SITE RASH (rash is around the injection site) and HEADACHE (Bad Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included TOPIRAMATE (TOPAMAX), ATENOLOL, ATORVASTATIN, LORAZEPAM, CELECOXIB (CELEBREX) and GABAPENTIN for an unknown indication.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced INJECTION SITE WARMTH (hot or warm to touch injection site), MIGRAINE (migraine), HYPOKINESIA (slightly difficult to move injected arm, can only move it one foot), VACCINATION SITE RASH (rash is around the injection site) and HEADACHE (Bad Headache). The patient was treated with OXYCODONE HYDROCHLORIDE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (hot or warm to touch injection site), MIGRAINE (migraine), HYPOKINESIA (slightly difficult to move injected arm, can only move it one foot) and VACCINATION SITE RASH (rash is around the injection site) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable. Permian, Amebic injection for migraine once a month is the other concomitant medications reported by reporter. Migraine medications are the other treatment medication reported by reporter. Permian,Amebic injection for migraine once a month is the other concomitant medications reported by reporter.   This case was linked to MOD21-026479 (E2B Linked Report).; Sender's Comments:  MOD21-026479:
Sex: M
Vaccine: COVID19
Symptoms: Amnesia
Clinical narrative: Memory loss; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (Memory loss) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AMNESIA (Memory loss). At the time of the report, AMNESIA (Memory loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact